3-Year Clinical Outcomes in the Randomized SORT OUT III Superiority Trial Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents

Michael Maeng; Hans-Henrik Tilsted; Lisette Okkels Jensen; Anne Kaltoft; Henning Kelbæk; Ulrik Abildgaard; Anton Boel Villadsen; Lars Romer Krusell; Jan Ravkilde; Knud Nørregaard Hansen; Evald Høj Christiansen; Jens Aarøe; Jan Skov Jensen; Steen Dalby Kristensen; Hans Erik Bøtker; Morten Madsen; Per Thayssen; Henrik Toft Sørensen; Leif Thuesen; Jens Flensted Lassen

doi:10.1016/j.jcin.2012.04.008

3-Year Clinical Outcomes in the Randomized SORT OUT III Superiority Trial Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents

Michael Maeng, Hans-Henrik Tilsted, Lisette Okkels Jensen, Anne Kaltoft, Henning Kelbæk, Ulrik Abildgaard, Anton Boel Villadsen, Lars Romer Krusell, Jan Ravkilde, Knud Nørregaard Hansen, Evald Høj Christiansen, Jens Aarøe, Jan Skov Jensen, Steen Dalby Kristensen, Hans Erik Bøtker, Morten Madsen, Per Thayssen, Henrik Toft Sørensen, Leif Thuesen, Jens Flensted Lassen

Research output: Contribution to journal › Journal article › Research › peer-review

38 Citations (Scopus)

Abstract

This study sought to examine the 3-year clinical outcomes in patients treated with the Endeavor (Medtronic, Santa Rosa, California) zotarolimus-eluting stent (ZES) or the Cypher (Cordis, Johnson & Johnson, Warren, New Jersey) sirolimus-eluting stent (SES) in routine clinical practice.

Original language	English
Journal	JACC. Cardiovascular interventions
Volume	5
Pages (from-to)	812-8
Number of pages	7
ISSN	1936-8798
DOIs	https://doi.org/10.1016/j.jcin.2012.04.008
Publication status	Published - 2012
Externally published	Yes

Bibliographical note

Access to Document

10.1016/j.jcin.2012.04.008

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Maeng, M., Tilsted, H-H., Jensen, L. O., Kaltoft, A., Kelbæk, H., Abildgaard, U., Boel Villadsen, A., Krusell, L. R., Ravkilde, J., Hansen, K. N., Christiansen, E. H., Aarøe, J., Jensen, J. S., Kristensen, S. D., Bøtker, H. E., Madsen, M., Thayssen, P., Sørensen, H. T., Thuesen, L., & Lassen, J. F. (2012). 3-Year Clinical Outcomes in the Randomized SORT OUT III Superiority Trial Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents. JACC. Cardiovascular interventions, 5, 812-8. https://doi.org/10.1016/j.jcin.2012.04.008

@article{72788b2a91d0436b8d71ed9d6156bff8,

title = "3-Year Clinical Outcomes in the Randomized SORT OUT III Superiority Trial Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents",

abstract = "This study sought to examine the 3-year clinical outcomes in patients treated with the Endeavor (Medtronic, Santa Rosa, California) zotarolimus-eluting stent (ZES) or the Cypher (Cordis, Johnson & Johnson, Warren, New Jersey) sirolimus-eluting stent (SES) in routine clinical practice.",

author = "Michael Maeng and Hans-Henrik Tilsted and Jensen, {Lisette Okkels} and Anne Kaltoft and Henning Kelb{\ae}k and Ulrik Abildgaard and {Boel Villadsen}, Anton and Krusell, {Lars Romer} and Jan Ravkilde and Hansen, {Knud N{\o}rregaard} and Christiansen, {Evald H{\o}j} and Jens Aar{\o}e and Jensen, {Jan Skov} and Kristensen, {Steen Dalby} and B{\o}tker, {Hans Erik} and Morten Madsen and Per Thayssen and S{\o}rensen, {Henrik Toft} and Leif Thuesen and Lassen, {Jens Flensted}",

year = "2012",

doi = "10.1016/j.jcin.2012.04.008",

language = "English",

volume = "5",

pages = "812--8",

journal = "JACC. Cardiovascular interventions",

issn = "1936-8798",

publisher = "Elsevier",

}

Maeng, M, Tilsted, H-H, Jensen, LO, Kaltoft, A, Kelbæk, H, Abildgaard, U, Boel Villadsen, A, Krusell, LR, Ravkilde, J, Hansen, KN, Christiansen, EH, Aarøe, J, Jensen, JS, Kristensen, SD, Bøtker, HE, Madsen, M, Thayssen, P, Sørensen, HT, Thuesen, L & Lassen, JF 2012, '3-Year Clinical Outcomes in the Randomized SORT OUT III Superiority Trial Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents', JACC. Cardiovascular interventions, vol. 5, pp. 812-8. https://doi.org/10.1016/j.jcin.2012.04.008

TY - JOUR

T1 - 3-Year Clinical Outcomes in the Randomized SORT OUT III Superiority Trial Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents

AU - Maeng, Michael

AU - Tilsted, Hans-Henrik

AU - Jensen, Lisette Okkels

AU - Kaltoft, Anne

AU - Kelbæk, Henning

AU - Abildgaard, Ulrik

AU - Boel Villadsen, Anton

AU - Krusell, Lars Romer

AU - Ravkilde, Jan

AU - Hansen, Knud Nørregaard

AU - Christiansen, Evald Høj

AU - Aarøe, Jens

AU - Jensen, Jan Skov

AU - Kristensen, Steen Dalby

AU - Bøtker, Hans Erik

AU - Madsen, Morten

AU - Thayssen, Per

AU - Sørensen, Henrik Toft

AU - Thuesen, Leif

AU - Lassen, Jens Flensted

PY - 2012

Y1 - 2012

N2 - This study sought to examine the 3-year clinical outcomes in patients treated with the Endeavor (Medtronic, Santa Rosa, California) zotarolimus-eluting stent (ZES) or the Cypher (Cordis, Johnson & Johnson, Warren, New Jersey) sirolimus-eluting stent (SES) in routine clinical practice.

AB - This study sought to examine the 3-year clinical outcomes in patients treated with the Endeavor (Medtronic, Santa Rosa, California) zotarolimus-eluting stent (ZES) or the Cypher (Cordis, Johnson & Johnson, Warren, New Jersey) sirolimus-eluting stent (SES) in routine clinical practice.

U2 - 10.1016/j.jcin.2012.04.008

DO - 10.1016/j.jcin.2012.04.008

M3 - Journal article

SN - 1936-8798

VL - 5

SP - 812

EP - 818

JO - JACC. Cardiovascular interventions

JF - JACC. Cardiovascular interventions

ER -

3-Year Clinical Outcomes in the Randomized SORT OUT III Superiority Trial Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents

Abstract

Bibliographical note

Access to Document

AUB Link

Fingerprint

Cite this